Showing results (1391-1400 of 3,550) with videos related to

Sort By:
Pageof 355
Thoracic Cancer|December 9, 2021
Effect of physical manipulation pulmonary rehabilitation on lung cancer patients after thoracoscopic lobectomyTing Zhou, Chao Sun
Thoracic Cancer|December 21, 2021
ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of ChinaChunfang Hu, Jiyan Dong, Li Liu, et al.
Thoracic Cancer|November 18, 2021
Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancerXiang Ji, Lisheng Xu, Pengfei Pan, et al.
Thoracic Cancer|November 20, 2021
Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgeryKentaro Miura, Kimihiro Shimizu, Seiki Hasegawa, et al.
Thoracic Cancer|December 25, 2021
MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathwayYang Li, Lingling Zu, Heng Wu, et al.
Thoracic Cancer|December 29, 2021
Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancerRyota Kikuchi, Hiroyuki Takoi, Mayuko Ishiwari, et al.
Thoracic Cancer|December 29, 2021
Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1-ALK fusionQiang Yin, Taiyan Guo, Yangyang Zhou, et al.
Thoracic Cancer|December 5, 2021
Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in JapanTomoko Shiraishi, Keishi Oda, Kei Yamasaki, et al.
Thoracic Cancer|January 5, 2022
Circ_0026134 promotes NSCLC progression by the miR-3619-5p/CHAF1B axisLiang Ge, Wei Tan, Guangcai Li, et al.
Thoracic Cancer|January 6, 2022
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancerYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Pageof 355